The Board of Humana shall consist of three to eight members according to the articles of association. Members of the Board shall together possess key skills and experience to ensure Humana’s optimum development. 

Board of Directors

Sören Mellstig, Strelsens ordförande

Sören Mellstig

Chairman of the board
Born 1951. Chairman of the board since 2019. Member of the audit committee and member of the remuneration committee.
 

Education
Bachelor of Applied Science, B.A.Sc. in Business Administration and General Management from Uppsala University.

Other current appointments
Chairman of Cellavision and Remeo. Board member of Ruth and Richard Julin foundation. Industrial Partner and co-founder of Impilo.

Previous appointments and professional experience
CEO of Gambro, managerial positions at Akzo Nobel and CFO and Vice President of Incentive. Chairman of Trelleborg, Apotek Hjärtat, Aleris, Ellevio, Ferrosan Medical Devices, Textilia and Delivery 1 Ltd.

Holdings per 2020-12-31
Own and closely associated holdings - 100,000 shares, 100,000 synthetic options 

Independent of the company and its executive management, however he is considered to have a connection with one of the major shareholders in the company.

More about Sören Mellstig Less about Sören Mellstig
Karita Bekkemellem, ledamot

Karita Bekkemellem

Board member
Born 1965. Board member since 2020.
 

Education
Studied at Forsvarets Høgskole in Norway.

Other current appointments
Since 2010, Managing Director of Legemiddelindustrien, LMI, the trade association for the Norwegian pharmaceutical industry.

Previous appointments and professional experience
Minister for Gender Equality, Children and Family and Member of Parlament for the Labor Party, Arbeiderpartiet, in Norway.

Holdings per 2020-12-31
Own and closely associated holdings - 0 shares, 10,000 synthetic options

Independent of the company and its executive management, as well as of major shareholders in the company

More about Karita Bekkemellem Less about Karita Bekkemellem
Kirsi Komi, ledamot

Kirsi Komi

Board member
Born 1963. Board member since 2017. Member of the audit committee.
 

Education
LL.M Master of Laws degree from University of Helsinki.

Other current appointments
Chairman of Docrates Cancer Centre in Helsinki and of the Directors' Institute of Finland. Board member of Metsä Board Oyj. 

Previous appointments and professional experience
Chairman of Lindström Invest Oy, Veikkaus Oy and the Blood Service under the Finnish Red Cross, vice chairman of Patria Oyj and board member of Bittium Oyj, Citycon Oyj, Martela Oyj and Finnvera Oyj. Managerial positions within the Nokia Group. 

Holdings per 2020-12-31
Own and closely associated holdings - 10,000 shares, 10,000 synthetic options

Independent in relation to Humana, the senior management and Humana’s major shareholders.

More about Kirsi Komi Less about Kirsi Komi
Monica Lingegård, ledamot

Monica Lingegård

Board member
Born 1962. Board member since 2017. Member of the audit committee and member of the remuneration committee.
 

Education
M.Sc.Econ, University of Stockholm.

Other current appointments
CEO of SJ. Chairman of Swedish Space Corporation Group.

Previous appointments and professional experience
CEO of Samhall and of G4S Secure Solutions. Board member of Nobina, Wireless Maingate, Swedish International Development Cooperation Agency (Sida), Orio, Svenskt Näringsliv and Almega. 

Holdings per 2020-12-31
Own and close related parties holdings - 1,500 shares, 10,000 synthetic options

Independent in relation to Humana, the senior management and Humana’s major shareholders.

More about Monica Lingegård Less about Monica Lingegård
Anders Nyberg, ledamot

Anders Nyberg

Board member
Born 1956. Board member since 2020. Member of the remuneration committee.


Education
Studied Business Administration and Economics at Stockholm University and graduated from the Swedish Institute of Higher Advertising, IHR (DIHR).

Other current appointments
CEO of Apotek Hjärtat. Chairman of the Board of Min Doktor.

Previous appointments and professional experience
Vice President of ICA and Axfood.

Holdings per 2021-02-15
Own and closely associated holdings - 11,000 shares, 10,000 synthetic options

Independent of the company and its executive management, as well as of major shareholders in the company.

More about Anders Nyberg Less about Anders Nyberg
Fredrik Strömholm, ledamot

Fredrik Strömholm

Board member
Born 1965. Board member since 2019. Chairman of the audit committee. 
 
Education
M.Sc. in Economics from the Stockholm School of Economics, with a major in finance at the Ecole des Hautes Etudes Commerciales in France; and studies in French, Russian and East European history at the universities of Uppsala and Stockholm. 
 
Other current appointments
Co-founder of Impilo and chairman of its investment committee, board member of Ferrosan Medical Devices, NutraQ, Ortic 3D, the Fertility Partnership and Euro Accident. He is also chairman of Natur and Kultur and board member of the college board of The Swedish School of Sport and Health Sciences, GIH.

Previous appointments and professional experience
Partner and founder at Altor Equity Partners for 14 years, managing director at Goldman Sachs International and investment manager at Nordic Capital.

Holdings per 2020-12-31
Own and closely associated holdings - 10,743,554 shares

Independent of the company and its executive management, however he is considered to have a connection with one of the major shareholders in the company.

More about Fredrik Strömholm Less about Fredrik Strömholm

The work of the Board

The Board of Humana has overall responsibility for building a valuecreating and sustainable business for shareholders with continuity and a long-term perspective. The Board is responsible for the Company’s overall strategy, ensuring well-informed decision-making processes and maintaining a clear perception of trends in the sector and Humana’s business environment. Another important function of the Board is to ensure that the company has good risk management, control and business monitoring.

The Board’s duties and responsibilities are regulated by the Swedish Companies Act and Humana’s Articles of Association. The Board’s work is also governed by annually defined rules of procedure, which describe areas such as the division of duties and responsibility between Board members, the Chairman and the CEO. The Board also draws up instructions for the Board’s committees. The Board of
Humana continuously monitors strategic direction, economic development and the Company’s methods and processes in order to maintain well-functioning operations. Humana’s Board is also responsible for ensuring good quality financial reporting and internal control and evaluating the business in relation to the goals and guidelines defined by the Board. The Chairman of the Board and the CEO are responsible for monitoring the Company’s development, and for preparing and leading Board meetings. The Chairman is also responsible for ensuring that Board members conduct an annual evaluation of their work and that they receive the information they need to perform their duties effectively and satisfactorily

The work of the board in 2020

Read about the Board's work during the latest reported year in the Corporate Governance Report, which is part of Humana's Annual Report.

Audit Committee

In accordance with the Code and the Companies Act, the Board of Directors of Humana has established from among its members an Audit committee. The Audit Committee’s main task is to support the Board in fulfilling its responsibilities in the areas of financial reporting, accounting, auditing, internal control and risk management. The Audit Committee works according to rules of procedure defined by the Board. The Committee’s duties also include reviewing internal audit procedures, and scrutinising and monitoring the auditor’s impartiality and independence. The Audit Committee has regular meetings with the auditors in order to keep informed about the focus and scope of the audit and observations arising from the audit.

Audit Committee members: 

  • Fredrik Strömholm, Chair
  • Kirsi Komi
  • Monica Lingegård
  • Sören Mellstig

The Chair of the Committee, Fredrik Strömholm, has the accounting expertise required by the Swedish Companies Act. All members of the Committee are independent of the Company. Kirsi Komi and Monica Lingegård are independent of the Company’s largest owner; Fredrik Strömholm and Sören Mellstig are not.

Remuneration Committee

In accordance with the Code and the Companies Act, the Board of Directors of Humana has established from among its members a Remuneration Committee. The Remuneration Committee works in accordance with rules of procedure adopted by the Board of Directors. The Remuneration Committee’s main tasks are to submit proposals to the Board on remuneration and conditions of employment for the President and CEO, and remuneration policies for Group management, and to monitor and evaluate current and completed incentive programmes. The Committee also makes decisions on remuneration and conditions of employment for other members of Group management. Remuneration Committee members are also responsible for monitoring and evaluating application of the guidelines for remuneration of senior executives adopted by the AGM. The Committee is also responsible for succession planning and talent management. 

Remuneration Committee members:

  • Sören Mellstig, Chair
  • Monica Lingegård
  • Fredrik Strömholm
  • Anders Nyberg

All members are independent of the Company and its management.

Board diversity policy

As a group, members of Humana’s Board should have the right expertise, experience and background to contribute to the Company’s development. The aim is for the Board to consist of members of varying ages, with both male and female representation, from varied geographical and ethnic backgrounds and complementing each other in terms of educational and professional backgrounds. The objective is for the Board to contribute independent and critical challenges.

The Board has adopted a diversity policy, which the Nomination Committee considers in the preparation of its proposal for the AGM. The Nomination Committee also bases its work on Section 4.1 of the Swedish Corporate Governance Code.

In 2017 and 2018, Humana was awarded the AllBright prize for the Company’s proactive gender equality work. The Company was also nominated for the AllBright prize in 2019 and one of three finalists in 2020.